Sandia Investment Management »

Rapport Therapeutics shares owned by Sandia Investment Management

Quarter-by-quarter ownership of Rapport Therapeutics shares owned by Sandia Investment Management from 13F filings

Historical chart of Sandia Investment Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Sandia Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Sandia Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $116k 5.0k 23.26

More positions owned by Sandia Investment Management

Lavoro Class A Ord (LVRO)
Sdcl Edge Acquisition Corp Cl A Ord Shs (SEDA)
Gores Holdings Ix Unit 01/14/2029 (GHIXU)
Sk Growth Opportunities Corp Class A Com (SKGR)
Haymaker Acquisition Corp Iv Unit 99/99/9999 (HYAC.U)
Dmy Squared Technology Group Cl A Com (DMYY)
Tortoiseecofin Acquisition C Shs Cl A (TRTL)
Churchill Capital Corp Vii Com Cl A (CVII)
Plum Acquisition Corp Iii Class A Ord Shs (PLMJ)
Concord Acquisition Corp Ii Com Cl A (CNDA)
Battery Future Acquisition C Cl A Ord Shs (BFAC)
Atlantic Coastal Aqstn Corp Class A Com (ACAB)
Pearl Holdings Acquisitn Cor Class A Ord Shs (PRLH)
Tmt Acquisition Corp SHS (TMTC)
Swiftmerge Acquisition Corp Class A Ord Shs (IVCP)

View all positions for Sandia Investment Management

Top funds holding Rapport Therapeutics

Arch Venture Corp
Cormorant Asset Management
Johnson & Johnson
Sofinnova Ventures
T. Rowe Price Investment Management
T. Rowe Price Associates
Alliancebernstein
Perceptive Advisors
Citadel Advisors
Artal Group
Logos Global Management
Woodline Partners
Millennium Management
TD Asset Management
Manufacturers Life Insurance Company

View all funds holding Rapport Therapeutics